What do systematic reviews say?

9 questions · 9 findings · 4 reviews · Schizophrenia

No studies found 9 · 100%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Economic outcome ‐ not reported · patients with schizophrenia

The review found no eligible studies for this question.

1 finding from 1 review

Pericyazine for schizophrenia 2014 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Economic outcome ‐ not reported · patients with schizophrenia

The review found no eligible studies for this question.

1 finding from 1 review

Pericyazine for schizophrenia 2014 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Economic outcome ‐ not reported · patients with schizophrenia

The review found no eligible studies for this question.

1 finding from 1 review

Perphenazine for schizophrenia 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Economic outcome ‐ not reported · patients with schizophrenia

The review found no eligible studies for this question.

1 finding from 1 review

Perphenazine for schizophrenia 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Economic outcomes ‐ long term ‐ not reported · patients with schizophrenia or related psychoses

The review found no eligible studies for this question.

1 finding from 1 review

Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders 2014 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Economic outcomes ‐ long term ‐ not reported · patients with schizophrenia or related psychoses

The review found no eligible studies for this question.

1 finding from 1 review

Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders 2014 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Economic outcomes ‐ long term ‐ not reported · patients with schizophrenia or related psychoses

The review found no eligible studies for this question.

1 finding from 1 review

Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders 2014 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Economic outcomes ‐ long term ‐ not reported · patients with schizophrenia or related psychoses

The review found no eligible studies for this question.

1 finding from 1 review

Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders 2014 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Economic outcomes ‐ costs of care ‐ long term ‐ not reported · patients with schizophrenia

The review found no eligible studies for this question.

1 finding from 1 review

Family intervention (brief) for schizophrenia 2014 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found